Fresenius Medical Care AG & Co. KGaA (FMS) Stock
FMS Key Statistics
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.
CEO: Shervin J. Korangy. Company website
FMS — Frequently Asked Questions
What is the FMS stock price today?
Fresenius Medical Care AG & Co. KGaA (FMS) trades at $22.22, down 2.29% on the day, as of Nov 12, 2026 09:30 UTC.
What is Fresenius Medical Care AG & Co. KGaA's market cap?
Fresenius Medical Care AG & Co. KGaA has a market capitalisation of $11.83B, calculated from the live FMS share price and shares outstanding.
What is the P/E ratio of FMS?
FMS trades at a trailing P/E of 14.81, from earnings per share of $1.50 over the last twelve months.
How much revenue does Fresenius Medical Care AG & Co. KGaA make?
Fresenius Medical Care AG & Co. KGaA generated revenue of $19.48B over the trailing twelve months, which puts the stock at 0.61 times sales.
Does FMS pay a dividend?
Yes. Fresenius Medical Care AG & Co. KGaA pays a dividend yielding 3.86% on the current share price.
What is the 52-week range for FMS?
FMS has traded between $20.02 and $26.42 over the past 52 weeks, and the last price is 15.9% below that high.
Is Fresenius Medical Care AG & Co. KGaA profitable?
Yes. Fresenius Medical Care AG & Co. KGaA keeps 4.22% of revenue as net income over the trailing twelve months.
What is the analyst price target for FMS?
Wall Street analysts rate FMS Hold, with an average price target of $23.67, 6.5% above the current price.
What sector is Fresenius Medical Care AG & Co. KGaA in?
Fresenius Medical Care AG & Co. KGaA is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in DE.
Who is the CEO of Fresenius Medical Care AG & Co. KGaA?
Shervin J. Korangy is the chief executive of Fresenius Medical Care AG & Co. KGaA, which employs 108,165 people.
Where can I track FMS in real time?
QFI Terminal shows FMS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See FMS live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open FMS in Terminal See plans